GlassScriptPhysician profile
Vincent M Leverett
NPI 1326058744
$2,402.36
in general payments reported to CMS, 2019-2025
33 companies · $850 in 2025
The $850 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $147 · 2021: $11.64 · 2022: $16.50 · 2023: $534 · 2024: $451 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,834.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $285.27 | 2023-2025 | |
| Glaxosmithkline, LLC. | $219.98 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $219.35 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $202.42 | 2019-2025 | |
| Novo Nordisk INC | $185.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $182.60 | 2019-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals LP | $150.93 | 2019-2024 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.79 | 2019-2025 | Jardiance, Tradjenta, Glyxambi |
| Hologic Sales and Service, LLC | $94.12 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Corcept Therapeutics | $71.66 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $71.06 | 2024-2025 | Voquezna |
| Insulet Corporation | $55.74 | 2025 | Omnipod |
| Exact Sciences Corporation | $48.37 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $44.19 | 2019-2023 | Veozah |
| Grifols USA, LLC | $43.42 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $40.32 | 2023 | |
| Alkermes, INC. | $37.02 | 2023-2025 | Lybalvi |
| Irhythm Technologies, INC. | $33.81 | 2023-2024 | Zio Xt Patch |
| Phadia US INC. | $24.49 | 2023 | Immunocap |
| Vertex Pharmaceuticals Incorporated | $24.25 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $23.92 | 2023 | Rexulti |
| Nevro Corp. | $22.64 | 2020 | |
| Seqirus USA INC | $21.76 | 2025 | Flucelvax, Fluad |
| Teva Pharmaceuticals USA, INC. | $21.72 | 2019 | |
| Inspire Medical Systems, INC. | $21.69 | 2025 | Inspire |
| Boston Scientific Corporation | $20.16 | 2020 | |
| Kaleo, INC. | $19.96 | 2019 | |
| Axsome Therapeutics, INC. | $18.10 | 2023 | Sunosi |
| Janssen Pharmaceuticals, INC | $16.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.63 | 2020 | |
| Allergan, INC. | $13.30 | 2019 | |
| Merck Sharp & Dohme LLC | $12.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Leverett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.